Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacturing, and commercialization of pharmaceutical products.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Pharmacy Market

JUBILANT HOLLISTERSTIER LLC ENTERS INTO COOPERATIVE AGREEMENT OF $149.6 MN WITH US GOVERNMENT TO EXPAND CRITICAL VACCINE MANUFACTURING CAPACITY

Jubilant Pharmova Limited | May 31, 2022

news image

Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer has entered into a cooperative agreement for $149.6 million (USD) with the Army Contracting Command, in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) on behalf of th...

Read More

Business Insights, PHARMA TECH

AVITA ACQUIRES Q CARE PLUS, RENAMES IT AVITA CARE SOLUTIONS

Avita Care Solutions | January 10, 2023

news image

PMQ Investors, LLC, the parent company of Avita, has acquired Q Care Plus, Inc. This community-focused care management solution offers stigma-free access to care via telehealth, focusing on telePrEP services. Meanwhile, the terms and conditions of the deal are yet to be revealed. "Bringing Avita and Q Care Plus together comes at a time when reducing health inequities among underserved populations is more critical than ever," said Avita Chief Executive Offi...

Read More

Pharmacy Market

CATALYST CLINICAL RESEARCH ANNOUNCES THE ACQUISITION OF GENPRO RESEARCH

PRNewswire | July 21, 2023

news image

Catalyst Clinical Research an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research ("Genpro"), a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland. Genpro is a next generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI enabled automation pr...

Read More

Pharmacy Market

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

news image

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More
news image

Pharmacy Market

JUBILANT HOLLISTERSTIER LLC ENTERS INTO COOPERATIVE AGREEMENT OF $149.6 MN WITH US GOVERNMENT TO EXPAND CRITICAL VACCINE MANUFACTURING CAPACITY

Jubilant Pharmova Limited | May 31, 2022

Jubilant Pharmova Limited has announced today that Jubilant Pharma Limited, a wholly owned subsidiary of the Company, through one of its wholly owned subsidiaries, Jubilant HollisterStier LLC, (JHS) a leading US-based pharmaceutical contract manufacturer has entered into a cooperative agreement for $149.6 million (USD) with the Army Contracting Command, in coordination with the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) on behalf of th...

Read More
news image

Business Insights, PHARMA TECH

AVITA ACQUIRES Q CARE PLUS, RENAMES IT AVITA CARE SOLUTIONS

Avita Care Solutions | January 10, 2023

PMQ Investors, LLC, the parent company of Avita, has acquired Q Care Plus, Inc. This community-focused care management solution offers stigma-free access to care via telehealth, focusing on telePrEP services. Meanwhile, the terms and conditions of the deal are yet to be revealed. "Bringing Avita and Q Care Plus together comes at a time when reducing health inequities among underserved populations is more critical than ever," said Avita Chief Executive Offi...

Read More
news image

Pharmacy Market

CATALYST CLINICAL RESEARCH ANNOUNCES THE ACQUISITION OF GENPRO RESEARCH

PRNewswire | July 21, 2023

Catalyst Clinical Research an industry-leading provider of specialized clinical development solutions, announced today it has acquired Genpro Research ("Genpro"), a Massachusetts-based global clinical research organization with staff in the US, India, and Ireland. Genpro is a next generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry with expertise in biometrics, medical writing, RWE, and AI enabled automation pr...

Read More
news image

Pharmacy Market

IAMA THERAPEUTICS ANNOUNCES INITIATION OF PRECLINICAL DEVELOPMENT STUDIES IN DRUG-RESISTANT EPILEPSY UNDER A SERVICE AGREEMENT WITH PSYCHOGENICS

IAMA Therapeutics | July 26, 2022

IAMA Therapeutics, a preclinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel medicines to make a difference in the lives of individuals suffering from brain disorders, and PsychoGenics Inc., a leader in AI-enabled phenotypic drug discovery and preclinical CRO services, today announced that the companies have entered into a service agreement to identify the efficacy of novel drug candidates in drug-resistant epilepsy. Under the...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us